Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 3,908

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

Open access
Molina, Julian R., Yang, Ping, Cassivi, Stephen D., Schild, Steven E., Adjei, Alex A.·2008·Mayo Clinic Proceedings
DOI 10.1016/s0025-6196(11)60735-0
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0025-6196(11)60735-0

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 104

  1. Jemal, 2008, Cancer statistics, 2008, CA Cancer J Clin, 58, 71, 10.3322/CA.2007.0010 · DOI · Paper page
  2. Navada, 2006, Temporal trends in small cell lung cancer: analysis of the national Surveillance Epidemiology and End-Results (SEER) database [abstract 7082], J Clin Oncol, 24, 384S
  3. Sher, 2008, Small cell lung cancer, Mayo Clin Proc, 83, 355, 10.4065/83.3.355 · DOI · Paper page
  4. Yang, 2005, Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003, Chest, 128, 452, 10.1378/chest.128.1.452 · DOI · Paper page
  5. Zhang, 2003, The impact of tobacco on lung health in China, Respirology, 8, 17, 10.1046/j.1440-1843.2003.00433.x · DOI
  6. Shaper, 2003, Pipe and cigar smoking and major cardiovascular events, cancer incidence and all-cause mortality in middle-aged British men, Int J Epidemiol, 32, 802, 10.1093/ije/dyg206 · DOI
  7. Henley, 2004, Association between exclusive pipe smoking and mortality from cancer and other diseases, J Natl Cancer Inst, 96, 853, 10.1093/jnci/djh144 · DOI
  8. Alberg, 2005, Epidemiology of lung cancer: looking to the future, J Clin Oncol, 23, 3175, 10.1200/JCO.2005.10.462 · DOI · Paper page
  9. Boffetta, 2006, Human cancer from environmental pollutants: the epidemiological evidence, Mutat Res, 608, 157, 10.1016/j.mrgentox.2006.02.015 · DOI · Paper page
  10. Hackshaw, 1997, The accumulated evidence on lung cancer and environmental tobacco smoke, BMJ, 315, 980, 10.1136/bmj.315.7114.980 · DOI · Paper page
  11. Whitrow, 2003, Environmental exposure to carcinogens causing lung cancer: epidemiological evidence from the medical literature, Respirology, 8, 513, 10.1046/j.1440-1843.2003.00497.x · DOI
  12. Vineis, 2005, Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study, BMJ, 330, 277, 10.1136/bmj.38327.648472.82 · DOI · Paper page
  13. Krinsky, 2005, Carotenoid actions and their relation to health and disease, Mol Aspects Med, 26, 459, 10.1016/j.mam.2005.10.001 · DOI · Paper page
  14. Ruano-Ravina, 2006, Antioxidant vitamins and risk of lung cancer, Curr Pharm Des, 12, 599, 10.2174/138161206775474396 · DOI
  15. Lam, 2005, Lung cancer in Asian women—the environment and genes, Respirology, 10, 408, 10.1111/j.1440-1843.2005.00723.x · DOI
  16. Siems, 2005, β-Carotene breakdown products may impair mitochondrial functions—potential side effects of high-dose β-carotene supplementation, J Nutr Biochem, 16, 385, 10.1016/j.jnutbio.2005.01.009 · DOI
  17. Freudenheim, 2005, Alcohol consumption and risk of lung cancer: a pooled analysis of cohort studies, Am J Clin Nutr, 82, 657, 10.1093/ajcn/82.3.657 · DOI
  18. Tardon, 2005, Leisure-time physical activity and lung cancer: a meta-analysis, Cancer Causes Control, 16, 389, 10.1007/s10552-004-5026-9 · DOI
  19. Alfano, 2004, Physical activity in relation to all-site and lung cancer incidence and mortality in current and former smokers, Cancer Epidemiol Biomarkers Prev, 13, 2233, 10.1158/1055-9965.2233.13.12 · DOI
  20. Kunzli, 2005, Air pollution: from lung to heart, Swiss Med Wkly, 135, 697
  21. Vineis, 2005, Air pollution and cancer: biomarker studies in human populations, Carcinogenesis, 26, 1846, 10.1093/carcin/bgi216 · DOI · Paper page
  22. Boffetta, 2004, Epidemiology of environmental and occupational cancer, Oncogene, 23, 6392, 10.1038/sj.onc.1207715 · DOI
  23. Hwang, 2003, Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk, Hum Genet, 113, 238, 10.1007/s00439-003-0968-7 · DOI
  24. Li, 2004, Inherited predisposition to early onset lung cancer according to histological type, Int J Cancer, 112, 451, 10.1002/ijc.20436 · DOI
  25. Bailey-Wilson, 2004, A major lung cancer susceptibility locus maps to chromosome 6p23-25, Am J Human Genet, 75, 460, 10.1086/423857 · DOI · Paper page
  26. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 [published online ahead of print April 2, 2008]. Nat Genet, doi:10.1038/ng.109. · DOI · Paper page
  27. Arita, 1995, Bronchogenic carcinoma: incidence of metastases to normal sized lymph nodes, Thorax, 50, 1267, 10.1136/thx.50.12.1267 · DOI
  28. Marom, 1999, Staging non-small cell lung cancer with whole-body PET, Radiology, 212, 803, 10.1148/radiology.212.3.r99se21803 · DOI · Paper page
  29. Weder, 1998, Detection of extrathoracic metastases by positron emission tomography in lung cancer, Ann Thorac Surg, 66, 886, 10.1016/S0003-4975(98)00675-4 · DOI
  30. Valk, 1995, Staging non-small cell lung cancer by whole-body positron emission tomographic imaging, Ann Thorac Surg, 60, 1573, 10.1016/0003-4975(95)00752-0 · DOI · Paper page
  31. Pieterman, 2000, Preoperative staging of non-small-cell lung cancer with positron-emission tomography, N Engl J Med, 343, 254, 10.1056/NEJM200007273430404 · DOI · Paper page
  32. Eloubeidi, 2005, Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans, Ann Thorac Surg, 79, 263, 10.1016/j.athoracsur.2004.06.089 · DOI
  33. Vilmann, 2005, Transesophageal endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) and endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) biopsy: a combined approach in the evaluation of mediastinal lesions, Endoscopy, 37, 833, 10.1055/s-2005-870276 · DOI
  34. Kim, 2004, Combined bronchoscopy, mediastinoscopy, and thoracotomy for lung cancer: who benefits?, J Thorac Cardiovasc Surg, 127, 850, 10.1016/j.jtcvs.2003.11.020 · DOI
  35. Kuzdal, 2005, Transcervical extended mediastinal lymphadenectomy—the new operative technique and early results in lung cancer staging, Eur J Cardiothorac Surg, 27, 384, 10.1016/j.ejcts.2004.12.008 · DOI
  36. Kuzdal, 2007, The transcervical extended mediastinal lymphadenectomy versus cervical mediastinoscopy in non-small cell lung cancer staging, Eur J Cardiothorac Surg, 31, 88, 10.1016/j.ejcts.2006.10.026 · DOI
  37. Henschke, 1999, Early Lung Cancer Action Project: overall design and findings from baseline screening, Lancet, 354, 99, 10.1016/S0140-6736(99)06093-6 · DOI · Paper page
  38. International Early Lung Cancer Action Program Investigators, 2006, Survival of patients with stage I lung cancer detected on CT screening, N Engl J Med, 355, 1763, 10.1056/NEJMoa060476 · DOI · Paper page
  39. US Preventive Services Task Force, 2004, Lung cancer screening: recommendation statement, Ann Intern Med, 140, 738, 10.7326/0003-4819-140-9-200405040-00014 · DOI
  40. Smith, 2001, American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers: also: update 2001—testing for early lung cancer detection, CA Cancer J Clin, 51, 38, 10.3322/canjclin.51.1.38 · DOI · Paper page
  41. Little, 2006, No nodes is good nodes [editorial], Ann Thorac Surg, 82, 4, 10.1016/j.athoracsur.2006.03.051 · DOI
  42. Ginsberg, 1995, Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer, Ann Thorac Surg, 60, 615, 10.1016/0003-4975(95)00537-U · DOI · Paper page
  43. Miller, 2002, Surgical treatment of non-small cell lung cancer 1 cm or less in diameter, Ann Thorac Surg, 73, 1545, 10.1016/S0003-4975(02)03525-7 · DOI
  44. Okada, 2005, Effect of tumor size on prognosis in patients with non-small cell lung cancer: the role of segmentectomy as a type of lesser resection, J Thorac Cardiovasc Surg, 129, 87, 10.1016/j.jtcvs.2004.04.030 · DOI · Paper page
  45. Yamato, 2001, Early results of a prospective study of limited resection for bronchioloalveolar adenocarcinoma of the lung, Ann Thorac Surg, 71, 971, 10.1016/S0003-4975(00)02507-8 · DOI
  46. Allen, 2006, Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial, Ann Thorac Surg, 81, 1013, 10.1016/j.athoracsur.2005.06.066 · DOI · Paper page
  47. Onaitis, 2006, Thoracoscopic lobectomy is a safe and versatile procedure: experience with 500 consecutive patients, Ann Surg, 244, 420, 10.1097/01.sla.0000234892.79056.63 · DOI
  48. McKenna, 2006, Video-assisted thoracic surgery lobectomy: experience with 1,100 cases, Ann Thorac Surg, 81, 421, 10.1016/j.athoracsur.2005.07.078 · DOI
  49. Dominguez-Ventura, 2006, Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection, Ann Thorac Surg, 82, 1175, 10.1016/j.athoracsur.2006.04.052 · DOI
  50. Pfister, 2004, American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: updated 2003, J Clin Oncol, 22, 330, 10.1200/JCO.2004.09.053 · DOI · Paper page
  51. Non-Small Cell Lung Cancer Collaborative Group, 1995, Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials, BMJ, 311, 899, 10.1136/bmj.311.7010.899 · DOI
  52. International Adjuvant Lung Cancer Trial Collaborative Group, 2004, Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer, N Engl J Med, 350, 351, 10.1056/NEJMoa031644 · DOI · Paper page
  53. Winton, 2005, Vinorelbine and cisplatin vs. observation in resected non-small-cell lung cancer, N Engl J Med, 352, 2589, 10.1056/NEJMoa043623 · DOI · Paper page
  54. Douillard, 2005, ANITA: phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): final results after 70-month median follow-up [abstract 7013], J Clin Oncol, 23, 624s
  55. Strauss, 2006, Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): update of Cancer and Leukemia Group B (CALGB) protocol 9633 [abstract 7007], J Clin Oncol, 24, 365s
  56. Xu, 2000, Adjuvant chemotherapy following radical surgery for non-small cell lung cancer: a randomized study on 70 patients, Chin Med J (Engl), 113, 617
  57. Mineo, 2001, Postoperative adjuvant therapy for stage IB non-small cell lung cancer, Eur J Cardiothorac Surg, 20, 378, 10.1016/S1010-7940(01)00779-5 · DOI
  58. Tada, 2002, Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer: lack of prognostic significance in DNA ploidy pattern at adjuvant setting [abstract 1250], Proc Am Soc Clin Oncol, 21, 313
  59. Imaizumi, 2005, Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer, Lung Cancer, 49, 85, 10.1016/j.lungcan.2004.11.025 · DOI
  60. Tada, 2004, A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 nonsmall cell lung cancer (JCOG9304), Lung Cancer, 43, 167, 10.1016/j.lungcan.2003.08.028 · DOI
  61. Nakagawa, 2005, A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I nonsmall-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG); the 4th study, Ann Oncol, 16, 75, 10.1093/annonc/mdi008 · DOI
  62. Endo, 2003, A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: north-east Japan Study Group for Lung Cancer Surgery, Lung Cancer, 40, 181, 10.1016/S0169-5002(03)00032-1 · DOI
  63. Kato, 2004, A randomized trial of adjuvant chemotherapy with Uracil-Tegafur for adenocarcinoma of the lung, N Engl J Med, 350, 1713, 10.1056/NEJMoa032792 · DOI · Paper page
  64. Barlesi, 2005, Should chemotherapy (Cx) for advanced non-small cell lung cancer (NSCLC) be platinum-based? a literature-based meta-analysis of randomized trials [abstract 7213], J Clin Oncol, 23, 673s
  65. D'Addario, 2005, Platinum-based versus non-platinum-based chemotherapy in advanced nonsmall-cell lung cancer: a meta-analysis of the published literature, J Clin Oncol, 23, 2926, 10.1200/JCO.2005.03.045 · DOI · Paper page
  66. Mendelsohn, 2003, Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer, J Clin Oncol, 21, 2787, 10.1200/JCO.2003.01.504 · DOI · Paper page
  67. Thatcher, 2005, Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer), Lancet, 366, 1527, 10.1016/S0140-6736(05)67625-8 · DOI · Paper page
  68. Kelly, 2005, J Clin Oncol, 23, 634s
  69. Perez-Soler, 2004, Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer, J Clin Oncol, 22, 3238, 10.1200/JCO.2004.11.057 · DOI · Paper page
  70. Shepherd, 2004, J Clin Oncol, 22, 622s
  71. Pao, 2004, EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc Natl Acad Sci U S A, 101, 13306, 10.1073/pnas.0405220101 · DOI · Paper page
  72. Sordella, 2004, Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways, Science, 305, 1163, 10.1126/science.1101637 · DOI · Paper page
  73. Sandler, 2005, Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C) with or without bevacizumab (NSC# 704865) in patients with advanced non-squamous, non-small-cell lung cancer (NSCLC): an Eastern Cooperative Oncology Group (ECOG) Trial E4599 [abstract 4], J Clin Oncol, 23, 2s
  74. Roswit, 1976, Survival with inoperable lung cancer: controlled national Veterans Administration study of radiation and chemotherapy, N Y State J Med, 76, 560
  75. Wolf, 1966, Controlled study of survival of patients with clinically inoperable lung cancer treated with radiation therapy, Am J Med, 40, 360, 10.1016/0002-9343(66)90131-8 · DOI
  76. Perez, 1985, Non-small cell carcinoma of the lung: dose-time parameters, Cancer Treat Symp, 2, 131
  77. Sause, 1995, Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable nonsmall-cell lung cancer, J Natl Cancer Inst, 87, 198, 10.1093/jnci/87.3.198 · DOI
  78. Schaake-Koning, 1992, Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer, N Engl J Med, 326, 524, 10.1056/NEJM199202203260805 · DOI · Paper page
  79. Le Chevalier, 1992, Significant effect of adjuvant chemotherapy on survival in locally advanced non-small-cell lung carcinoma [letter], J Natl Cancer Inst, 84, 58, 10.1093/jnci/84.1.58 · DOI
  80. Furuse, 1999, Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer, J Clin Oncol, 17, 2692, 10.1200/JCO.1999.17.9.2692 · DOI · Paper page
  81. Onishi, 2004, Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study, Cancer, 101, 1623, 10.1002/cncr.20539 · DOI · Paper page
  82. Bush, 2004, Hypofractionated proton beam radiotherapy for stage I lung cancer, Chest, 126, 1198, 10.1378/chest.126.4.1198 · DOI
  83. Miyamoto, 2003, Carbon ion radiotherapy for stage I non-small cell lung cancer, Radiother Oncol, 66, 127, 10.1016/S0167-8140(02)00367-5 · DOI
  84. Sun, 2006, Histologic grade is an independent prognostic factor for survival in non-small cell lung cancer: an analysis of 5018 hospital- and 712 population-based cases, J Thorac Cardiovasc Surg, 131, 1014, 10.1016/j.jtcvs.2005.12.057 · DOI
  85. Ebbert, 2003, Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women, J Clin Oncol, 21, 921, 10.1200/JCO.2003.05.085 · DOI
  86. Schild, 2005, Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly, Cancer, 103, 2349, 10.1002/cncr.21034 · DOI
  87. Hanna, 2005, Randomized, phase III trial comparing irinotecan/cisplatin (IP) with etoposide/cisplatin (EP) in patients (pts) with previously untreated, extensive-stage (ES) small cell lung cancer (SCLC) [abstract 7004], J Clin Oncol, 23, 622s
  88. Shigematsu, 2006, Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers, Int J Cancer, 118, 257, 10.1002/ijc.21496 · DOI · Paper page
  89. Janne, 2005, Epidermal growth factor receptor mutations in non-small-cell lung cancer: implications for treatment and tumor biology, J Clin Oncol, 23, 3227, 10.1200/JCO.2005.09.985 · DOI · Paper page
  90. Calvo, 2006, Ethnic differences in response to epidermal growth factor receptor tyrosine kinase inhibitors, J Clin Oncol, 24, 2158, 10.1200/JCO.2006.06.5961 · DOI
  91. Rosell, 2003, Influence of genetic markers on survival in non-small cell lung cancer, Drugs Today (Barc), 39, 775, 10.1358/dot.2003.39.10.799471 · DOI
  92. Qiao, 2004, Concurrent radiotherapy combined with carboplatin and etoposide in limited stage small cell lung cancer [in Chinese], Zhonghua Jie He He Hu Xi Za Zhi, 27, 237
  93. Gurubhagavatula, 2004, XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy, J Clin Oncol, 22, 2594, 10.1200/JCO.2004.08.067 · DOI · Paper page
  94. Bradley, 2005, Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma, Int J Radiat Oncol Biol Phys, 61, 318, 10.1016/j.ijrobp.2004.06.260 · DOI · Paper page
  95. Connell, 2004, Relevance and irrelevance of DNA damage response to radiotherapy, DNA Repair (Amst), 3, 1245, 10.1016/j.dnarep.2004.04.004 · DOI
  96. Willers, 2004, Repair of radiation damage to DNA, Br J Cancer, 90, 1297, 10.1038/sj.bjc.6601729 · DOI
  97. Schild, 2002, Phase III trial comparing chemotherapy plus once-daily or twice-daily radiotherapy in stage III non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 54, 370, 10.1016/S0360-3016(02)02930-9 · DOI
  98. Sugimura, 2006, Long-term survivorship in lung cancer, Chest, 129, 1088, 10.1378/chest.129.4.1088 · DOI
  99. Visbal, 2004, Gender differences in nonsmall cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997-2002, Ann Thorac Surg, 78, 209, 10.1016/j.athoracsur.2003.11.021 · DOI · Paper page
  100. Ko, 2003, Evaluating health utility in patients with melanoma, breast cancer, colon cancer, and lung cancer: a nation-wide, population-based assessment, J Surg Res, 114, 1, 10.1016/S0022-4804(03)00167-7 · DOI
  101. Thomas, 1993, Malignant disease appearing late after operation for T1 N0 non-small-cell lung cancer, J Thorac Cardiovasc Surg, 106, 1053, 10.1016/S0022-5223(19)33977-7 · DOI
  102. Komaki, 1997, Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588, Int J Radiat Oncol Biol Phys, 39, 537, 10.1016/S0360-3016(97)00365-9 · DOI
  103. Bonner, 1998, The possible advantage of hyperfractionated thoracic radiotherapy in the treatment of locally advanced nonsmall cell lung carcinoma: results of a North Central Cancer Treatment Group Phase III Study, Cancer, 82, 1037, 10.1002/(SICI)1097-0142(19980315)82:6<1037::AID-CNCR5>3.3.CO;2-4 · DOI
  104. Tucker, 1997, Second primary cancers related to smoking and treatment of small-cell lung cancer, J Natl Cancer Inst, 89, 1782, 10.1093/jnci/89.23.1782 · DOI

Cited by

See all 3,908

Metadata

Authors
Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E., & Adjei, A. A.
Venue
Mayo Clinic Proceedings
Publisher
Elsevier BV
Published
2008-05
Volume
83
Issue
5
Pages
584-594
ISSN
0025-6196 (ISSN-L)
DOI
10.1016/s0025-6196(11)60735-0
OpenAlex
W2054841768
Cited by
3,908
References
8
FWCI
52.59
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. https://app.cochat.ai/papers/10.1016/s0025-6196(11)60735-0
The paper
Molina, J. R., Yang, P., Cassivi, S. D., Schild, S. E., & Adjei, A. A. (2008). Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship. Mayo Clinic Proceedings. https://doi.org/10.1016/s0025-6196(11)60735-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.